Lysine-specific demethylase 1 (lsd1)-mediated epigenetic modification of immunogenicity and immunomodulatory effects in breast cancers

HIGHLIGHTS

• who: Dong Yeul Lee and collaborators from the Department of Anatomical Pathology, General Hospital, College Road, Academia, Level, School of Biological Sciences, Nanyang Technological University, Nanyang Drive, Parkville, VIC, Australia have published the article: Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers, in the Journal: (JOURNAL)
• what: The authors focus on the underlying basis of antitumor immunity nogenicity and the abysmal immunotherapy response ratean seen in breast cancers. tumor and how targeting epigenetic marker LSD1 can provide avenue to modulate immunogenicity and the abysmal immunotherapy response rate . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.